Perrigo introduces generic Olux-E Foam, 0.05%

NewsGuard 100/100 Score

Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has launched clobetasol emulsion propionate foam, 0.05%, the generic equivalent  of Olux® -E Foam, 0.05%. Perrigo will commence shipment of the product immediately. As Perrigo was the first generic filer against this product, it has 180 days of generic exclusivity. The launch date was agreed upon in a 2012 litigation settlement between Perrigo and GlaxoSmithKline.

Clobetasol emulsion propionate foam, 0.05% is indicated for the treatment of moderate to severe dermatosis of the scalp. Generic annual sales were approximately $38 million, as measured by Symphony Health Solutions.

Perrigo's Chairman, President and CEO Joseph C. Papa stated, "This is the second product launched since the acquisition of Cobrek and it's another example of our Rx team's commitment to launching difficult to manufacture products. We are excited to market this product and are dedicated to making quality healthcare more affordable."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.